损伤相关细胞标志物在疫苗诱导免疫性血栓性血小板减少症临床与病理特征中的作用
研究纳入22例住院VITT患者、9例ChAdOx1疫苗接种前对照和21例接种后对照,分析细胞因子、细胞死亡标志物、中性粒细胞胞外诱捕网及凝血指标,并分析死亡患者组织标本。结果显示VITT患者存在强烈免疫炎症反应、内皮与凝血激活,约70%(15/22)符合国际血栓与止血学会DIC标准;淋巴细胞减少和循环组蛋白水平可独立预测28天死亡。
要点
- 约70%(15/22)VITT患者符合ISTH的DIC标准,而凝血酶原时间变化轻微。
- VITT患者存在显著升高的促炎细胞因子及Th1、Th2细胞活化。
- 淋巴细胞减少和循环组蛋白水平独立预测VITT患者28天死亡。
核心结论
- 全身细胞损伤与死亡偶联强烈的免疫炎症和凝血反应,在重症VITT中具有病理生理主导作用和临床相关性。
研究设计与样本
- 研究纳入22例住院VITT患者、9例ChAdOx1疫苗接种前对照和21例接种后对照,标本来自英国英格兰多地。
- 检测入院血样的细胞因子谱、细胞死亡标志物(乳酸脱氢酶和循环组蛋白)、中性粒细胞胞外诱捕网及凝血参数,并分析死亡患者组织标本。
主要发现
- VITT患者促炎细胞因子显著升高,Th1和Th2细胞活化显著增强。
- VITT患者循环和器官切片中全身内皮活化及凝血活化标志物均显著升高。
- 约70%(n=15/22)VITT患者符合国际血栓与止血学会DIC标准,而凝血酶原时间变化轻微。
- 中性粒细胞胞外诱捕网形成增加,伴显著淋巴细胞减少、乳酸脱氢酶升高和循环组蛋白水平升高,提示全身免疫细胞损伤或死亡。
- 淋巴细胞减少和循环组蛋白水平均独立预测VITT患者28天死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adenoviral vector-based COVID-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) is rare but carries significant risks of mortality and long-term morbidity. The underlying pathophysiology of severe disease is still not fully understood. The objectives were to explore the pathophysiological profile and examine for clinically informative biomarkers in patients with severe VITT. METHODS: Twenty-two hospitalized patients with VITT, 9 pre- and 21 post-ChAdOx1 vaccine controls, were recruited across England, United Kingdom. Admission blood samples were analyzed for cytokine profiles, cell death markers (lactate dehydrogenase and circulating histones), neutrophil extracellular traps, and coagulation parameters. Tissue specimens from deceased patients were analyzed. RESULTS: There were strong immune responses characterized by significant elevations in proinflammatory cytokines and T helper 1 and 2 cell activation in patients with VITT. Markers of systemic endothelial activation and coagulation activation in both circulation and organ sections were also significantly elevated. About 70% (n = 15/22) of patients met the International Society for Thrombosis and Haemostasis criteria for disseminated intravascular coagulation despite negligible changes in the prothrombin time. The increased neutrophil extracellular trap formation, in conjunction with marked lymphopenia, elevated lactate dehydrogenase, and circulating histone levels, indicates systemic immune cell injury or death. Both lymphopenia and circulating histone levels independently predicted 28-day mortality in patients with VITT. CONCLUSION: The coupling of systemic cell damage and death with strong immune-inflammatory and coagulant responses are pathophysiologically dominant and clinically relevant in severe VITT.
引用
- Abrams ST, Du M, Shaw RJ, et al. Damage-associated cellular markers in the clinical and pathogenic profile of vaccine-induced immune thrombotic thrombocytopenia. J Thromb Haemost. 2023. PMID: 38103733. doi:10.1016/j.jtha.2023.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。